FDA approves Tzield (teplizumab-mzwv) to delay onset of type 1 diabetes | Carrick Pharmacy
(Carrick Pharmacy News) The US Food and Drug Administration (FDA) has given the green light to a first-in-class diabetes injection. This new approval is found under the name Tzield (teplizumab-mzwv). It’s an injection given once daily for 14 consecutive days. The FDA approved it to delay the onset of stage 3 type 1 diabetes in both adults …
